# First-in-human Clinical Trial to Assess Safety and Efficacy of the CardiaZn Bioresorbable Stent in Children With Pulmonary Artery Stenosis and Aortic Coarctation

> **NCT07628101** · NA · NOT_YET_RECRUITING · sponsor: **PediaStent LLC** · enrollment: 45 (estimated)

## Conditions studied

- Aortic Coarctation, Pulmonary Artery Stenosis

## Interventions

- **DEVICE:** CardiaZn Bioresorbable Stent

## Key facts

- **NCT ID:** NCT07628101
- **Lead sponsor:** PediaStent LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2031-10
- **Final completion:** 2031-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628101, "First-in-human Clinical Trial to Assess Safety and Efficacy of the CardiaZn Bioresorbable Stent in Children With Pulmonary Artery Stenosis and Aortic Coarctation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*